US OptionsDetailed Quotes
BLCO241220P15000
- 0.10
- +0.05+100.00%
15min DelayClose Dec 13 16:00 ET
0.10High0.10Low
0.10Open0.05Pre Close1 Volume611 Open Interest15.00Strike Price10.00Turnover137.38%IV19.89%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0725Delta0.0474Gamma186.00Leverage Ratio-0.0399Theta-0.0002Rho-13.49Eff Leverage0.0029Vega
Bausch + Lomb Corp. Stock Discussion
Sign in to post a comment
In today’s market, one of the biggest winners generating outsized interest is $Emergent BioSolutions (EBS.US)$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...
The company’s turnaround efforts appear to be receiving a jolt today, wit...
8
1
1
1
Upgrades
• $Argo Group International (ARGO.US)$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache (APA.US)$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway (CNI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway (CP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology (CRS.US)$ : Cowen Upgra...
• $Argo Group International (ARGO.US)$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache (APA.US)$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway (CNI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway (CP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology (CRS.US)$ : Cowen Upgra...
7
1
1
Upgrades
• $Argo Group International (ARGO.US)$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache (APA.US)$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway (CNI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway (CP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology (CRS.US)$ : Cowen Upgr...
• $Argo Group International (ARGO.US)$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache (APA.US)$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway (CNI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway (CP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology (CRS.US)$ : Cowen Upgr...
12
2
2
Upgrades
• $Zymergen (ZY.US)$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy (CHWY.US)$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B (PARA.US)$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc (ROKU.US)$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group (UBS.US)$: BofA Securities Downgrades to Neutral from Buy - P...
• $Zymergen (ZY.US)$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy (CHWY.US)$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B (PARA.US)$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc (ROKU.US)$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group (UBS.US)$: BofA Securities Downgrades to Neutral from Buy - P...
16
1
10
7
4
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Upgrades
• $American Water Works (AWK.US)$ : Janney Upgrades to Buy from Neutral
• $Becton Dickinson & Co (BDX.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $275
• $Altria (MO.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $43 (from $47)
• $Middlesex Water (MSEX.US)$ : Janney Upgrades to Buy from Neutral
• $Indonesia Energy (INDO.US)$ : Noble Capital Upgrades to Outperform from Market Perform - PT...
• $American Water Works (AWK.US)$ : Janney Upgrades to Buy from Neutral
• $Becton Dickinson & Co (BDX.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $275
• $Altria (MO.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $43 (from $47)
• $Middlesex Water (MSEX.US)$ : Janney Upgrades to Buy from Neutral
• $Indonesia Energy (INDO.US)$ : Noble Capital Upgrades to Outperform from Market Perform - PT...
24
2
4
Upgrades
• $Ardagh Metal (AMBP.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $9
• $American Express (AXP.US)$ : Edward Jones Upgrades to Buy from Hold
• $CrowdStrike (CRWD.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195)
• $Lululemon Athletica (LULU.US)$ : Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260)
• $ResMed (RMD.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...
• $Ardagh Metal (AMBP.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $9
• $American Express (AXP.US)$ : Edward Jones Upgrades to Buy from Hold
• $CrowdStrike (CRWD.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195)
• $Lululemon Athletica (LULU.US)$ : Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260)
• $ResMed (RMD.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...
12
1
GOLDMAN SACHS
• $Bausch + Lomb Corp. (BLCO.US)$ Goldman Sachs analyst Amit Hazan initiated coverage of Bausch + Lomb with a Neutral rating and $22 price target, implying 22% upside potential. The analyst sees Bausch + Lomb's current offering and pipeline as positioning it well to maintain or expand share in the "attractive and durable' eye care market.
• $Steel Dynamics (STLD.US)$ Goldman Sachs analyst Emily Chieng downgraded Steel Dynamics to Neutral...
• $Bausch + Lomb Corp. (BLCO.US)$ Goldman Sachs analyst Amit Hazan initiated coverage of Bausch + Lomb with a Neutral rating and $22 price target, implying 22% upside potential. The analyst sees Bausch + Lomb's current offering and pipeline as positioning it well to maintain or expand share in the "attractive and durable' eye care market.
• $Steel Dynamics (STLD.US)$ Goldman Sachs analyst Emily Chieng downgraded Steel Dynamics to Neutral...
21
31
Upgrades
• $Grab Holdings (GRAB.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $3.04
• $Linde (LIN.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $355
• $Magellan Midstream (MMP.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $56 (from $54)
• $Mercury Systems (MRCY.US)$: Baird Upgrades to Outperform from Neutral - PT $72 (from $56)
• $Nurix Therapeutics (NRIX.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT...
• $Grab Holdings (GRAB.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $3.04
• $Linde (LIN.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $355
• $Magellan Midstream (MMP.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $56 (from $54)
• $Mercury Systems (MRCY.US)$: Baird Upgrades to Outperform from Neutral - PT $72 (from $56)
• $Nurix Therapeutics (NRIX.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT...
16
3
7
No comment yet
Benjamin’s : New CEO